Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21992533 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Conditions: Kidney Transplantation;   Chronic Kidney Failure
Interventions: Drug: Cyclosporine (CsA);   Drug: Belatacept LI (less intensive);   Drug: Belatacept MI (more intensive)

Indicates status has not been verified in more than two years